Tiago Ricardo Moreira

Dr. Tiago Ricardo Moreira

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DGDanilo Lemes Naves Gonçalves
Danilo Lemes Naves Gonçalves
TMTiago Ricardo Moreira
Tiago Ricardo Moreira
LSLuciana Saraiva da Silva
Luciana Saraiva da Silva
The function of uric acid (UA) in the genesis and evolution of chronic kidney disease (CKD) has motivated numerous studies, but the results remain inconclusive. We sought to conduct a systematic review and meta-analysis of cohort studies aiming to analyze the association of UA levels with the incidence and progression of CKD. Pubmed/Medline, Lilacs/Bireme and Web of Science were searched to identify eligible studies, following the PRISMA protocol. Data were presented for CKD incidence and progression separately. For the meta-analysis, studies with data stratified by subgroups according to serum UA levels were selected. The inverse variance-weighted random effects model was used to generate a combined effect estimate. Meta-regressions were performed to identify the causes of heterogeneity. The Newcastle–Ottawa Scale was used to assess the risk of bias. The publication bias was tested by funnel plot and Egger’s test. Eighteen CKD incidence studies (n = 398,663) and six CKD progression studies (n = 13,575) were included. An inverse relationship was observed between UA levels and protection from CKD incidence and progression. Lower UA levels were protective for the risk of CKD incidence (RR 0.65 [95% CI 0.56–0.75]) and progression (RR 0.55 [95% CI 0.44–0.68]). UA seems to be implicated both in the genesis of CKD and its evolution.

7 May 2023 in Public Health
Verified
Journal Article
Closed access
JSJ.R. Mudadu Silva
J.R. Mudadu Silva
LVL.L. Vieira
L.L. Vieira
AAA.R. Murta Abreu
A.R. Murta Abreu
EFEmily Ferreira
Emily Ferreira
TMTiago Ricardo Moreira
Tiago Ricardo Moreira
RCRosângela Minardi Mitre Cotta
Rosângela Minardi Mitre Cotta

29 November 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
IGIRENE DA SILVA ARAÚJO GONÇALVES
IRENE DA SILVA ARAÚJO GONÇALVES
MFMariana De Santis Filgueiras
Mariana De Santis Filgueiras
TMTiago Ricardo Moreira
Tiago Ricardo Moreira
MMMilena Sales Thomé Milena
Milena Sales Thomé Milena
MPMONICA E D PEREIRA
MONICA E D PEREIRA
GCGlauce Dias da Costa
Glauce Dias da Costa
Background/Objectives: Obesity is influenced by biological, hormonal, and social factors, contributing to chronic diseases and burdening the healthcare system. Chronic stress and emotional eating are linked to weight gain, affecting eating behaviors and metabolism. This study aimed to assess the association between stress, eating behavior, and adiposity in obese women. Methods: This cross-sectional study included 132 obese women from Viçosa, Minas Gerais, Brazil. The participants completed the Lipp Stress Symptoms Inventory and the Dutch Eating Behavior Questionnaire. Blood samples were collected to measure plasma cortisol, and Body Mass Index (BMI) was calculated from weight and height measurements. Body fat was assessed using dual-energy X-ray absorptiometry (DXA). Associations between stress, eating behavior, and adiposity were evaluated using linear regression models, and interactions between stress and eating behavior subscales were tested. Results: Positive associations were observed between Phases I (alert), II (resistance), and III (exhaustion) of stress with emotional and external eating. A negative association was identified between dietary restraint and body fat, especially in women with lower cortisol levels (<13.7 mg/dL). Additionally, the alert phase was associated with higher android fat in these women. Conclusions: The findings support the hypothesis that stress and eating behavior are associated with body adiposity and that stress is linked to emotional and external eating. An inverse association between restrained eating and body fat was observed in women with lower cortisol levels. These results highlight the importance of an interdisciplinary approach that incorporates emotional and stress conditions in obesity treatment.

1 January 2019 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
MPMirna Brito Peçanha
Mirna Brito Peçanha
RFRodrigo de Barros Freitas
Rodrigo de Barros Freitas
TMTiago Ricardo Moreira
Tiago Ricardo Moreira
LSLuiz Sérgio Silva
Luiz Sérgio Silva
Leandro Licursi De OliveiraLeandro Licursi De Oliveira
Leandro Licursi De Oliveira
SCSílvia Almeida Cardoso
Sílvia Almeida Cardoso
Objective: To determine the prevalence of vitamin D deficiency/insufficiency in children 0-18 years of age with recurrent wheezing and/or asthma residing in the microregion of Viçosa, Minas Gerais, Brazil, and treated at a referral center, and to determine its association with major risk factors for wheezing. Methods: A cross-sectional study was performed using a semi-structured questionnaire, which was administered by trained interviewers to the legal guardians of the study participants. Data were obtained regarding general characteristics of recurrent wheezing; general sociodemographic, environmental, and biologic factors; and atopy-related factors. The magnitude of the statistical association was assessed by calculating ORs and their corresponding 95% CIs by using multiple logistic regression. Results: We included 124 children in the study. The prevalence of vitamin D deficiency/insufficiency in the sample was 57.3%. Vitamin D deficiency/insufficiency was found to be associated with wheezing in the first year of life, personal history of atopic dermatitis, environmental pollution, and vitamin D supplementation until 2 years of age. Conclusions: The prevalence of vitamin D deficiency/insufficiency was high in our sample. Vitamin D concentrations were directly associated with vitamin D supplementation until 2 years of age and were inversely associated with wheezing events in the first year of life, personal history of atopic dermatitis, and environmental pollution.

1 November 2016 in Public Health
Verified
Journal Article
Closed access
LSLuciana Saraiva da Silva
Luciana Saraiva da Silva
RCRosângela Minardi Mitre Cotta
Rosângela Minardi Mitre Cotta
TMTiago Ricardo Moreira
Tiago Ricardo Moreira
RSR.G. da Silva
R.G. da Silva
CRC. de O.B. Rosa
C. de O.B. Rosa
MBM.A.P. Bastos
M.A.P. Bastos

1 January 2020 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
LCLuma de O Comini
Luma de O Comini
LOLaura C de Oliveira
Laura C de Oliveira
LBLuiza D Borges
Luiza D Borges
HDHeloisa H Dias
Heloisa H Dias
CBClara R S Batistelli
Clara R S Batistelli
RCRosângela Minardi Mitre Cotta
Rosângela Minardi Mitre Cotta
Purpose: To identify the associations between MetS and its components and chronic kidney disease (CKD) in a population with arterial hypertension (AH), or diabetes mellitus (DM) accompanied by the Primary Health Care (PHC). Patients and methods: A cross-sectional study with 788 individuals diagnosed with AH and/or DM followed by PHC of Viçosa, Brazil. Anthropometric, biochemical and clinical measures were performed for the diagnosis of MetS and CKD. MetS was identified using the NCEP-ATPIII criteria. CKD was identified by estimating the glomerular filtration rate using the CKD-EPI equation. Logistic regression models were used to estimate the chances of CKD associated with MetS and its components and specific combinations of components. Results: The prevalence of MetS reported in the population was 65.4%, that of hidden CKD was 15.4%. The prevalence of CKD among participants with MetS was 75.2%. The most prevalent component of MetS in the population was AH (96.7%). Elevated fasting blood glucose, central obesity, and reduced HDL-c were significantly associated with an increased chance of CKD (OR = 2.80, 95% CI 1.76–4.45, OR = 1.68, 95% CI, 05–2.71, OR = 1.61, CI 95% 1.03–2.50, respectively). For the multivariate adjustment, the participants with MetS were 2 times more likely to have CKD than those without MetS (OR = 2.07; 95% CI, 1.25–3.44). The combination of three components of MetS high blood pressure, abdominal obesity and elevated fasting blood glucose and the combination of four components of MetS high blood pressure, reduced HDL-c, high fasting blood glucose and abdominal obesity were associated with increased odds of CKD (OR = 2.67, CI 95% 1.70–4.20, OR = 2.50, CI 95% 1.55–4.02, respectively). Conclusion: MetS, as well as its individual or combined components were independently associated with CKD in the population with AH and/or DM accompanied by PHC.